240 related articles for article (PubMed ID: 18800213)
1. Genetic polymorphisms in venous thrombosis and pulmonary embolism after total hip arthroplasty: a pilot study.
Ringwald J; Berger A; Adler W; Kraus C; Pitto RP
Clin Orthop Relat Res; 2009 Jun; 467(6):1507-15. PubMed ID: 18800213
[TBL] [Abstract][Full Text] [Related]
2. Combined genetic mutations have remarkable effect on deep venous thrombosis and/or pulmonary embolism occurence.
Simsek E; Yesilyurt A; Pinarli F; Eyerci N; Ulus AT
Gene; 2014 Feb; 536(1):171-6. PubMed ID: 24334115
[TBL] [Abstract][Full Text] [Related]
3. Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature.
Lenicek Krleza J; Jakovljevic G; Bronic A; Coen Herak D; Bonevski A; Stepan-Giljevic J; Roic G
Pathophysiol Haemost Thromb; 2010; 37(1):24-9. PubMed ID: 20664190
[TBL] [Abstract][Full Text] [Related]
4. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
[TBL] [Abstract][Full Text] [Related]
5. Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis.
Kupeli E; Verdi H; Simsek A; Atac FB; Eyuboglu FO
Clin Appl Thromb Hemost; 2011; 17(6):E87-94. PubMed ID: 21078611
[TBL] [Abstract][Full Text] [Related]
6. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
[TBL] [Abstract][Full Text] [Related]
7. Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty.
Philipp CS; Dilley A; Saidi P; Evatt B; Austin H; Zawadsky J; Harwood D; Ellingsen D; Barnhart E; Phillips DJ; Hooper WC
Thromb Haemost; 1998 Dec; 80(6):869-73. PubMed ID: 9869151
[TBL] [Abstract][Full Text] [Related]
8. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
[TBL] [Abstract][Full Text] [Related]
9. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
Procare-GEHT Group
Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
[TBL] [Abstract][Full Text] [Related]
10. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
[TBL] [Abstract][Full Text] [Related]
11. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
[TBL] [Abstract][Full Text] [Related]
12. Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.
Ben Salem-Berrabah O; Fekih-Mrissa N; N'siri B; Ben Hamida A; Benammar-Elgaaied A; Gritli N; Mrissa R
J Clin Neurosci; 2012 Sep; 19(9):1326-7. PubMed ID: 22721898
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis.
Nizankowska-Mogilnicka E; Adamek L; Grzanka P; Domagala TB; Sanak M; Krzanowski M; Szczeklik A
Eur Respir J; 2003 Jan; 21(1):25-30. PubMed ID: 12570104
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of factor V leiden, MTHFR C677T and MTHFR A1298C polymorphisms in patients with deep vein thrombosis in Central Iran.
Ehsani M; Imani A; Moravveji A
Mol Biol Rep; 2018 Aug; 45(4):621-624. PubMed ID: 29855758
[TBL] [Abstract][Full Text] [Related]
15. A preliminary study of inherited thrombophilic risk factors in different clinical manifestations of venous thromboembolism in central Iran.
Karimi A; Abolhasani M; Hashemzadeh-Chaleshtori M; Pourgheysari B
Indian J Med Res; 2015 Jul; 142(1):46-52. PubMed ID: 26261166
[TBL] [Abstract][Full Text] [Related]
16. [Mutation frequencies of the thrombophilic state genes in Uzbekistan].
Sadikova ShE; Karimov KhIa; Muminov ShM; Tulakov RP; Boboev KT
Tsitol Genet; 2008; 42(6):50-4. PubMed ID: 19253755
[TBL] [Abstract][Full Text] [Related]
17. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism].
Avdonin PV; Kirienko AI; Kozhevnikova LM; Shostak NA; Babadaeva NM; Leont'ev SG; Petukhov EB; Kubatiev AA; Savel'ev VS
Ter Arkh; 2006; 78(6):70-6. PubMed ID: 16881367
[TBL] [Abstract][Full Text] [Related]
18. The 2007 John Charnley Award. Factors leading to low prevalence of DVT and pulmonary embolism after THA: analysis of genetic and prothrombotic factors.
Kim YH; Kim JS
Clin Orthop Relat Res; 2007 Dec; 465():33-9. PubMed ID: 17693875
[TBL] [Abstract][Full Text] [Related]
19. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.
Bezemer ID; Doggen CJ; Vos HL; Rosendaal FR
Arch Intern Med; 2007 Mar; 167(5):497-501. PubMed ID: 17353498
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
